Skip to main content
. 2021 Dec 29;23(7):772–778. doi: 10.22074/cellj.2021.7984

Fig.2.

Fig.2

Trends of forced vital capacity (FVC) and revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) percent during 12 months follow-up. FVC percent declined rapidly up to 4 months after infusion, but we can see a moderate elevation between months 4 and 6. After 6 months, the progression of respiratory disturbances was observed. ALSFRS-R score, significantly decreased after infusion. Data are mean ± SEM.